The Immunology Program at the NCI-designated Moffitt Cancer Center in Tampa, Florida (USA) welcomes applications for NIH-funded Postdoctoral Fellowships to investigate fundamental mechanisms involved in anti-tumor immunity. Key areas of emphasis are (a) tumor and microenvironment cross-talk in controlling anti-tumor T cell responses and (b) development of novel adenovirus-based anti-tumor vaccines.
Key references include:
(1) Valenzuela JO et al. An essential requirement for PKC-theta in T cell alloreactivity and graft-versus-host-disease. J. Clin. Invest. 2009; 119(12): 3774-86.
(2) Hopewell EL et al. IKK-beta induced inflammation impacts the kinetics but not the magnitude of the immune response to a viral vector. Eur J Immunol. 2012; 42(3): 681-7.
(3) Hopewell EL et al. Lung tumor NF-kappa B signaling promotes T cell-mediated immune surveillance. J. Clin. Invest. Published online May 1 2013.
(2) Hopewell EL et al. IKK-beta induced inflammation impacts the kinetics but not the magnitude of the immune response to a viral vector. Eur J Immunol. 2012; 42(3): 681-7.
(3) Hopewell EL et al. Lung tumor NF-kappa B signaling promotes T cell-mediated immune surveillance. J. Clin. Invest. Published online May 1 2013.
Preference will be given to individuals who have recently graduated with a Ph.D. degree in immunology or related field. Individuals with experience in immune assays, molecular biology, viral vaccines and mouse models will be preferred. Independence in initiating, conducting, evaluating and reporting of research studies is essential. Excellent verbal and written communication skills are required. Moffitt Cancer Center has state-of-the-art core facilities for cell therapy and immunotherapeutics, flow cytometry, proteomics, gene profiling, and transgenic mouse models.
To apply: Candidates should apply online at www.moffitt.org/careers to REQ ID 10910 and include a cover letter briefly summarizing research interests and career goals, CV, and contact information for three academic references.